ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) Institutional Ownership

CUSIP: 032797300

13F Institutional Holders and Ownership History from Q4 2015 to Q4 2025

Type / Class
Equity / COM NEW
Symbol
AVXL on Nasdaq
Price per share
$4.36
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
37,789,992
Total reported value
$135,892,658
% of total 13F portfolios
0%
Share change
+5,536,076
Value change
+$14,995,730
Number of holders
179
Price from insider filings
$4.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 032797300?
CUSIP 032797300 identifies AVXL - ANAVEX LIFE SCIENCES CORP. - COM NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 179 institutional investors reported holding 37,789,992 shares of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL).

Institutional Holders of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 37,789,992 $135,892,658 +$14,995,730 $3.56 179
2025 Q3 32,468,725 $289,473,061 -$273,984 $8.90 184
2025 Q2 32,493,276 $301,726,227 +$10,099,066 $9.22 175
2025 Q1 31,369,737 $269,176,514 +$13,007,772 $8.58 178
2024 Q4 29,547,094 $316,161,065 +$29,473,787 $10.74 167
2024 Q3 26,968,911 $153,149,572 -$533,003 $5.68 142
2024 Q2 26,760,101 $112,930,616 -$18,825,367 $4.22 135
2024 Q1 30,948,610 $157,506,940 +$27,304,520 $5.09 140
2023 Q4 25,832,104 $240,513,953 +$8,316,479 $9.31 146
2023 Q3 25,058,666 $164,128,831 -$1,892,057 $6.55 140
2023 Q2 25,281,347 $205,636,828 -$14,163,807 $8.13 143
2023 Q1 27,108,237 $232,269,844 +$393,430 $8.57 139
2022 Q4 27,002,000 $250,064,092 +$22,831,014 $9.26 136
2022 Q3 24,372,403 $251,469,999 -$6,293,663 $10.32 139
2022 Q2 24,888,142 $249,199,961 -$1,729,547 $10.01 142
2022 Q1 24,991,414 $307,685,297 +$32,689,444 $12.31 131
2021 Q4 22,100,211 $383,138,229 +$25,372,466 $17.34 142
2021 Q3 20,580,263 $369,399,670 -$25,050,093 $17.95 131
2021 Q2 21,526,442 $492,165,210 +$81,312,363 $22.86 124
2021 Q1 18,187,562 $271,803,006 +$79,133,906 $14.95 101
2020 Q4 13,964,886 $75,410,516 +$6,571,033 $5.40 88
2020 Q3 12,684,452 $57,699,630 +$3,160,613 $4.55 75
2020 Q2 11,946,714 $58,843,561 +$1,942,364 $4.92 74
2020 Q1 11,691,929 $36,823,316 -$5,016,089 $3.15 65
2019 Q4 13,916,000 $36,043,597 +$1,117,491 $2.59 59
2019 Q3 13,289,318 $41,993,556 +$4,737,912 $3.16 54
2019 Q2 11,767,055 $39,650,063 +$14,871,644 $3.37 55
2019 Q1 7,377,719 $22,501,197 +$2,167,483 $3.05 51
2018 Q4 6,715,415 $10,473,190 -$2,650,363 $1.56 44
2018 Q3 8,213,369 $22,311,576 -$2,312,830 $2.73 44
2018 Q2 9,088,737 $23,812,662 -$3,161,313 $2.62 52
2018 Q1 10,279,544 $28,366,015 +$325,912 $2.76 53
2017 Q4 10,135,530 $32,634,077 +$289,125 $3.22 56
2017 Q3 10,036,457 $41,546,671 -$980,609 $4.14 60
2017 Q2 10,290,140 $54,735,640 +$4,823,505 $5.32 56
2017 Q1 9,371,190 $53,788,000 +$19,419,492 $5.74 53
2016 Q4 7,507,035 $29,724,887 +$11,510,670 $3.96 58
2016 Q3 4,582,303 $16,628,382 +$2,565,105 $3.63 51
2016 Q2 3,826,280 $23,378,725 +$10,539,944 $6.11 44
2016 Q1 2,161,346 $10,589,000 +$3,670,757 $4.90 39
2015 Q4 1,369,818 $7,628,000 +$7,625,000 $5.57 28